Intelligence · Drug directory
Pipeline & Investigational Drugs
Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
Quick answer
Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
-
lanolin alcohol-containing product
EUCERIN
-
lavender spike oil
NULL
-
lazertinib mesilate hydrate
LAZCLUZE
-
ledipasvir acetonate/sofosbuvir
HARVONI
-
lenalidomide hydrate
REVLIMID PARTIAL CHANGE APPROVAL
-
lenvatinib mesilate
LENVIMA INITIAL APPROVAL
-
linctuses containing codeine phosphate
NULL
-
linctuses, other
NULL
-
liquorice liquid extract
NULL
-
lotions
NULL
-
magnesium carbonate light
NULL
-
magnesium sulfate (may only be prescribed for other than oral use)
NULL
-
magnesium trisilicate
NULL
-
magnesium trisilicate and belladonna
NULL
-
mecobalamin
ROZEBALAMIN
-
medium chain triglycerides
MCT OIL
-
menthol and eucalyptus
NULL
-
menthol, racemic or levomenthol
NULL
-
methyl hydroxybenzoate
NULL
-
methyl hydroxybenzoate solution
NULL
-
methyl salicylate + menthol + camphor + eucalyptus oil + pine oil pumilio + turpentine oil + peppermint oil + cajuput oil + capsicum extract
GOANNA HEAT CREAM
-
methylated industrial spirit (use as additive only)
NULL
-
methylnaltrexone
RELISTOR
-
milk powder synthetic low calcium
LOCASOL
Frequently asked questions
How many pipeline drugs are listed?
1,610 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.